Tumor Ablation Market to Reach $7.5 billion, Globally, by 2035 at 13.6% CAGR: Allied Market Research

Wilmington, Delaware, March 04, 2025 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, and Other Ablation Technologies), Treatment (Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), and Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Bone Cancer, and Other): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “tumor ablation market” was valued at $1.6 billion in 2023, and is estimated to reach $7.5 billion by 2035, growing at a CAGR of 13.6% from 2024 to 2035. 

Request Sample of the Report on Global Tumor Ablation Market 2035 – https://www.alliedmarketresearch.com/request-sample/A17208 

Prime determinants of growth 

Increase in the prevalence of cancer, rise in demand for minimally invasive treatments, and government initiatives and reimbursement policies are the major factors that drive the growth of the tumor ablation market. However, the high costs of ablation equipment and complications and side-effects associated with tumor ablation treatment may restrict market growth. Moreover, the expanding healthcare infrastructure in emerging countries and technological advancements in tumor ablation devices are expected to present new opportunities in the coming years. 

Report coverage & details 

Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A17208 

The radiofrequency ablation segment held the largest market share in 2023. 

By technology, the radiofrequency ablation segment held the largest market share in 2023, accounting for around one-third of the tumor ablation market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to its proven effectiveness, widespread clinical acceptance, and ability to treat a wide range of tumors, particularly in the liver, kidney, and lung. Radiofrequency ablation offers advantages such as minimal invasiveness, lower risk of complications, and faster recovery times, making it a preferred choice for both healthcare providers and patients. 

However, the microwave ablation segment is expected to register the highest CAGR of 14.6% during the forecast period. This is attributed to its ability to generate higher temperatures more efficiently, enabling faster and larger tumor ablation with minimal collateral damage to surrounding tissues. Microwave ablation also offers advantages in treating tumors that are larger or located in difficult-to-reach areas, where other techniques like radiofrequency may be less effective. 

The percutaneous ablation segment held the largest market share in 2023. 

By treatment, the percutaneous ablation segment held the largest market share in 2023, accounting for more than half of the tumor ablation market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to its minimally invasive nature, which offers patients reduced recovery times, lower risks of complications, and less postoperative pain compared to traditional surgery. The procedure can be performed under local anesthesia, often as an outpatient treatment, making it a cost-effective option. 

However, the laparoscopic ablation segment is expected to register the highest CAGR of 13.8% during the forecast period. This is attributed to its ability to offer more precise tumor targeting with minimal invasiveness, providing benefits such as smaller incisions, reduced scarring, and faster recovery times compared to traditional open surgery. Laparoscopic ablation allows for direct visualization of tumors, improving treatment accuracy and outcomes. 

The liver cancer segment held the largest market share in 2023. 

By application, the liver cancer segment held the largest market share in 2023, accounting for one-third of the tumor ablation market revenue and is estimated to maintain its leadership status throughout the forecast period owing to the rise in prevalence of liver cancer globally, particularly in regions with high rates of hepatitis and alcohol-related liver disease. Tumor ablation techniques, such as radiofrequency and microwave ablation, are effective in treating liver cancer due to their ability to target localized tumors with minimal disruption to healthy tissue. 

However, the kidney cancer segment is expected to register the highest CAGR of 14.1% during the forecast period. This is attributed to the increase in incidence of kidney cancer globally, along with the growing preference for minimally invasive treatment options, such as tumor ablation, which offers lower risks and faster recovery compared to traditional surgery. 

North America held the largest market share in 2023. 

North America dominated the market share in 2023, accounting for around half of the tumor ablation market revenue, owing to the rise in prevalence of cancer, advanced healthcare infrastructure, and strong reimbursement policies that support the adoption of cutting-edge medical technologies. The region benefits from a robust presence of key market players and continuous innovation in tumor ablation technologies, such as improved imaging techniques and device advancements. However, Asia-Pacific is expected to register the highest CAGR of 14.6% during the forecast period owing to rise in incidence of cancer, particularly liver and lung cancers, and the growing adoption of advanced medical technologies in countries such as China, India, and Japan. The region is witnessing improvements in healthcare infrastructure, making minimally invasive treatments such as tumor ablation more accessible. 

For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/A17208 

Leading Market Players 

• Integra LifeSciences Holdings Corporation 

• Boston Scientific Corporation 

The report provides a detailed analysis of these key players in the tumor ablation market. These players have adopted strategies such as product approval, acquisition, clinical trial expansion, and agreement to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario 

Trending Reports in Healthcare Industry:  

Point of Care Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

Contraceptives Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

Electrophysiology Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

Orphan Drugs Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 

David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter